S
Sudhir Diwan
Researcher at Lenox Hill Hospital
Publications - 68
Citations - 4935
Sudhir Diwan is an academic researcher from Lenox Hill Hospital. The author has contributed to research in topics: Chronic pain & Lumbar. The author has an hindex of 27, co-authored 61 publications receiving 4250 citations. Previous affiliations of Sudhir Diwan include Cornell University & Texas Tech University.
Papers
More filters
Journal ArticleDOI
Ischemic pain in the extremities and Raynaud's phenomenon.
Jacques Devulder,Hans van Suijlekom,Robert van Dongen,Sudhir Diwan,Nagy Mekhail,Maarten van Kleef,Frank J P M Huygen +6 more
TL;DR: Two important groups of disorders result from an insufficient blood supply to the extremities: critical vascular disease and the Raynaud’s phenomenon.
Journal ArticleDOI
Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Shalini Shah,Sudhir Diwan,Amol Soin,Kartic Rajput,Amit Mahajan,Laxmaiah Manchikanti,Alan D. Kaye,Joshua A Hirsch,Christopher Gharibo +8 more
TL;DR: These guidelines are considered evidence -- informed with incorporation of best available research and practice knowledge and steps must be taken to stratify risks and protect patients from possible infection to safeguard them from COVID-19-related illness and transmitting the disease to others.
Journal ArticleDOI
Guidelines for the proper use of epidural steroid injections for the chronic pain patient
TL;DR: Evidence-based guidelines are established for the first time in an attempt to provide the interventional pain physician with specific guidelines concerning the administration of epidural steroids in patients with axial and radicular pain of spinal origin.
Journal ArticleDOI
COVID-19 pandemic - a narrative review of the potential roles of chloroquine and hydroxychloroquine
Carlos Marcelo de Barros,Carolina Aparecida de Faria Almeida,Bruna Pinheiro Pereira,Karla Cristinne Mancini Costa,Flaviane A Pinheiro,Livia Del Bianco Maia,Cristiano M Trindade,Raphael Caio Tamborelli Garcia,Larissa Helena Torres,Sudhir Diwan,Vanessa Bergamin Boralli +10 more
TL;DR: Evaluating the evidence regarding the efficacy and safety of CQ and HCQ used against viral infection caused by SARS-CoV-2 found that both drugs may increase the risk of cardiac arrhythmias, leading to cardiac arrest and sudden death.
Journal ArticleDOI
Safety and effectiveness of intravascular mesenchymal stem cells to treat organ failure and possible application in covid-19 complications
Sairam Atluri,Vivek Manocha,Navneet Boddu,Sachi Bhati,Zaid Syed,Sudhir Diwan,Laxmaiah Manchikanti +6 more
TL;DR: MSC therapy seems to be promising to treat multiorgan failure from COVID-19, with positive outcomes among the 6 studies that specifically assessed the effectiveness of MSC therapy in ARDS, and 4 showed positive outcomes.